Ketaki Bhate

Ketaki Bhate

Biography

Ketaki Bhate

Doctoral Research Fellow at London School of Hygiene and Tropical Medicine, United Kingdom

Dr. Ketaki Bhate is a Doctoral Research Fellow at the London School of Hygiene and Tropical Medicine in London, and an honorary consultant dermatologist. Her research and clinical interests are in acne vulgaris in particularly its epidemiology. She trained at the Centre of Evidence Based Dermatology in Nottingham and recently completed a funded research fellowship at the University of Pennsylvania.

Short Description of the Lecture:

  1. Epidemiology of Acne Vulgaris: What’s New and Important for the Patient?
    Acne vulgaris is both pathophysiologically and epidemiologically multifactorial. While the pathophysiological steps involved in the formation of an acne lesion are relatively well defined, how epidemiological causes, for example diet, lifestyle and other potential risk factors, relate to acne is less clear. In the past few years there has been a surge of studies addressing the causes of acne using various study designs and of varying quality. The aims of this talk are to summarise what recent advances have been made about the causes of acne including a critique of the literature and if these advances are applicable to clinical practice for the ultimate benefit of the patient
  2. Antibiotics and Isotretinoin for Acne – What’s New and What the Future May Hold
    Since the 1980s isotretinoin has transformed the landscape of acne treatment however there have been developments recently regarding the potential risks of treatment in the literature and there remains variability in prescribing practices across different healthcare settings. This talk will review and critique the recent literature regarding isotretinoin and its applicability to the patient in clinic. In addition, this talk will discuss the recent literature regarding the risk profile and effectiveness of antibiotics for acne, both oral and topical, which have been the mainstay of acne treatment in those with moderate to severe acne for decades. Lastly, what the future may hold with regard to acne therapy will be discussed.